It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In 2015, ~800,000 people died by suicide worldwide. For every death by suicide there are as many as 25 suicide attempts, which can result in serious injury even when not fatal. Despite this large impact on morbidity and mortality, the genetic influences on suicide attempt are poorly understood. We performed a genome-wide association study (GWAS) of severity of suicide attempts to investigate genetic influences. A discovery GWAS was performed in Yale-Penn sample cohorts of European Americans (EAs, n = 2,439) and African Americans (AAs, n = 3,881). We found one genome-wide significant (GWS) signal in EAs near the gene LDHB (rs1677091, p = 1.07 × 10−8) and three GWS associations in AAs: ARNTL2 on chromosome 12 (rs683813, p = 2.07 × 10−8), FAH on chromosome 15 (rs72740082, p = 2.36 × 10−8), and on chromosome 18 (rs11876255, p = 4.61 × 10−8) in the Yale-Penn discovery sample. We conducted a limited replication analysis in the completely independent Army-STARRS cohorts. rs1677091 replicated in Latinos (LAT, p = 6.52 × 10−3). A variant in LD with FAH rs72740082 (rs72740088; r2 = 0.68) was replicated in AAs (STARRS AA p = 5.23 × 10−3; AA meta, 1.51 × 10−9). When combined for a trans-population meta-analysis, the final sample size included n = 20,153 individuals. Finally, we found significant genetic overlap with major depressive disorder (MDD) using polygenic risk scores from a large GWAS (r2 = 0.007, p = 6.42 × 10−5). To our knowledge, this is the first GWAS of suicide attempt severity. We identified GWS associations near genes involved in anaerobic energy production (LDHB), circadian clock regulation (ARNTL2), and catabolism of tyrosine (FAH). These findings provide evidence of genetic risk factors for suicide attempt severity, providing new information regarding the molecular mechanisms involved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Nuñez, Yaira Z 1 ; Jain, Sonia 2 ; He, Feng 2 ; Sun, Xiaoying 2 ; Ursano, Robert J 3 ; Kessler, Ronald C 4 ; Smoller, Jordan W 5 ; Stein, Murray B 6
; Kranzler, Henry R 7
; Gelernter, Joel 8
1 Yale University School of Medicine, Division of Human Genetics, Department of Psychiatry, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Veterans Affairs Connecticut Healthcare Center, Department of Psychiatry, West Haven, USA (GRID:grid.47100.32)
2 University of California San Diego, Department of Family Medicine and Public Health, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
3 Uniformed Services University of the Health Sciences, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525)
4 Harvard Medical School, Department of Health Care Policy, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
5 Harvard Medical School, Department of Psychiatry, Massachusetts General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research, Cambridge, USA (GRID:grid.66859.34)
6 University of California San Diego, Department of Family Medicine and Public Health, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); University of California San Diego, Department of Psychiatry, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); VA San Diego Healthcare System, San Diego, USA (GRID:grid.410371.0) (ISNI:0000 0004 0419 2708)
7 University of Pennsylvania Perelman School of Medicine, Department of Psychiatry, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); Crescenz Veterans Affairs Medical Center, Veterans Integrated Service Network 4 Mental Illness Research, Education and Clinical Center, Philadelphia, USA (GRID:grid.410355.6) (ISNI:0000 0004 0420 350X)
8 Yale University School of Medicine, Division of Human Genetics, Department of Psychiatry, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Veterans Affairs Connecticut Healthcare Center, Department of Psychiatry, West Haven, USA (GRID:grid.47100.32); Yale University School of Medicine, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University School of Medicine, Department of Neuroscience, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)




